Prognostic value of newborn hearing screening in patients with myelomeningocele

David Satzer1, Daniel J Guillaume

  • 1Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota.

Insights

Failure of newborn hearing screening (NHS) may indicate future brainstem dysfunction in infants with myelomeningocele (MMC). This finding can aid in early assessment and surgical planning for these patients.

Area of Science:

  • Pediatric Neurology
  • Neonatal Care
  • Neurosurgery

Background:

  • Brainstem dysfunction affects a subset of myelomeningocele (MMC) patients, often associated with Chiari Type II malformation.
  • Early identification and intervention, such as craniocervical decompression, are crucial for reducing mortality in at-risk MMC patients.
  • Auditory brainstem response abnormalities are common in children with MMC.

Purpose of the Study:

  • To investigate if failed newborn hearing screening (NHS) can predict brainstem dysfunction in neonates with myelomeningocele (MMC).
  • To assess the utility of NHS as a screening tool for identifying MMC patients at risk for neurological complications.

Main Methods:

  • Retrospective chart review of 40 newborns with MMC and 50 controls in a neonatal intensive care unit.
  • Examination of NHS results, brainstem symptoms, demographics, and surgical history.
  • Analysis of differences in brainstem symptom presence and onset based on NHS outcomes.

Main Results:

  • Failure of NHS was significantly more common in MMC newborns who developed brainstem symptoms (31%) compared to controls (0%).
  • MMC patients who failed NHS showed a higher incidence of brainstem symptoms (80%) versus those who passed (26%).
  • Delayed respiratory symptom onset was observed in MMC patients who failed NHS (median 16 months) compared to those who passed (median 0 months).

Conclusions:

  • Newborn hearing screening (NHS) results may serve as a predictive indicator for brainstem dysfunction in myelomeningocele (MMC) patients.
  • Incorporating NHS outcomes into prognostic assessments could enhance surgical decision-making for MMC patients.
  • NHS failure warrants further investigation for potential neurological complications in infants with MMC.
Abstract

Related Concept Videos